Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

Gordon Chu*, Jaap Seelig, Emmy M. Trinks-Roerdink, Anouk P. van Alem, Marco Alings, Bart van den Bemt, Lucas V. A. Boersma, Marc A. Brouwer, Suzanne C. Cannegieter, Hugo ten Cate, Charles J. H. J. Kirchhof, Harry J. G. M. Crijns, Ewoud J. van Dijk, Arif Elvan, Isabelle C. van Gelder, Joris R. de Groot, Frank R. den Hartog, Jonas S. S. G. de Jong, Sylvie de Jong, Frederikus A. KlokTimo Lenderink, Justin G. Luermans, Joan G. Meeder, Ron Pisters, Peter Polak, Michiel Rienstra, Frans Smeets, Giovanni J. M. Tahapary, Luc Theunissen, Robert G. Tieleman, Serge A. Trines, Pepijn van der Voort, Geert-Jan Geersing, Frans H. Rutten, Martin Ew Hemels, Menno Huisman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number036220
Number of pages9
JournalBMJ Open
Volume10
Issue number8
DOIs
Publication statusPublished - Aug 2020

Keywords

  • ADHERENCE
  • ANTICOAGULANTS
  • BLEEDING RISK
  • DABIGATRAN
  • MANAGEMENT
  • OUTCOMES
  • PERSISTENCE
  • RIVAROXABAN
  • STROKE RISK
  • WARFARIN USE
  • adult cardiology
  • cardiac epidemiology
  • protocols & guidelines
  • thromboembolism
  • BELIEFS

Cite this